NEW YORK (GenomeWeb) – OncoDNA said today that CyberKnife Sigulda will market and distribute its tumor profiling solutions for clinical use in Latvia.

Financial and other terms of the deal were not disclosed.

Gosselies, Belgium-based OncoDNA's solutions guide oncologists in their treatment decision-making based on a solid or liquid molecular characterization of a tumor. They include tumor interrogation technologies — such as NGS, immunohistochemistry, and pyrosequencing — combined with an extensive clinical literature assessment, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.